Literature DB >> 31771492

Non-Communicable Diseases on the Rise in Sub-Saharan Africa, the Underappreciated Threat of a Dual Disease Burden.

Herry Mapesi1,2,3, Daniel Henry Paris2,3.   

Abstract

In sub-Saharan Africa, the burden of non-communicable diseases (NCDs) remains under appreciated, but emerging evidence suggests it to be substantial. NCDs such as arterial hypertension, heart diseases, diabetes mellitus and chronic kidney diseases are especially relevant, and put additional strain on the already challenged health systems in this region. Moreover, NCDs appear to be associated with higher mortality and morbidity rates and are more common in younger population groups, in people from sub-Saharan Africa when compared to more developed countries. In this review, we summarize the current literature on the burden of NCDs in sub-Saharan Africa, and highlight the clinical implications of the most relevant etiologies, i.e. arterial hypertension, heart diseases, diabetes mellitus and chronic kidney diseases.

Entities:  

Keywords:  Afrique subsaharienne; Maladies non transmissibles; Nicht übertragbare Krankheiten; Nierenerkrankungen; Non-communicable diseases; Subsahara-Afrika; arterial hypertension; arterielle Hypertonie; doppelte Krankheitsbelastung; double charge de morbidité; dual disease burden; hypertension artérielle; kidney diseases; maladies rénales; sub-Saharan Africa

Mesh:

Year:  2019        PMID: 31771492     DOI: 10.1024/1661-8157/a003354

Source DB:  PubMed          Journal:  Praxis (Bern 1994)        ISSN: 1661-8157


  2 in total

Review 1.  African genetic diversity and adaptation inform a precision medicine agenda.

Authors:  Luisa Pereira; Leon Mutesa; Paulina Tindana; Michèle Ramsay
Journal:  Nat Rev Genet       Date:  2021-01-11       Impact factor: 53.242

2.  The coArtHA trial-identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: study protocol for a randomized controlled trial.

Authors:  Thilo Burkard; Maja Weisser; Herry Mapesi; Ravi Gupta; Herieth Ismael Wilson; Blaise Lukau; Alain Amstutz; Aza Lyimo; Josephine Muhairwe; Elizabeth Senkoro; Theonestina Byakuzana; Madavida Mphunyane; Moniek Bresser; Tracy Renée Glass; Mark Lambiris; Günther Fink; Winfrid Gingo; Manuel Battegay; Daniel Henry Paris; Martin Rohacek; Fiona Vanobberghen; Niklaus Daniel Labhardt
Journal:  Trials       Date:  2021-01-21       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.